β¨ Medicine Distribution Consents
116 NEW ZEALAND GAZETTE No. 4
NZ Sponsor:
Schering-Plough Pty Limited
Manufacturer(s):
Schering-Plough Limited, Singapore
Product:
Asmanex Twisthaler
Active Ingredient(s):
Mometasone furoate 400Β΅g/dose
Dosage Form:
Powder for inhalation
NZ Sponsor:
Schering-Plough Pty Limited
Manufacturer(s):
Schering-Plough Limited, Singapore
Product:
Clomhexal
Active Ingredient(s):
Clomiphene citrate 50mg
Dosage Form:
Tablet
NZ Sponsor:
Hexal New Zealand Limited
Manufacturer(s):
Heumann Pharma GmbH (Manufacturing Facility), Plant II, Feucht, Germany
Salutas Pharma GmbH, Barleben, Germany
Product:
Zolaten
Active Ingredient(s):
Aciclovir 5% w/w
Dosage Form:
Topical cream
NZ Sponsor:
Pharmaco (NZ) Limited
Manufacturer(s):
Chefaro International BV, Rotterdam, The Netherlands
Dated this 12th day of January 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go389
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the act and are set out in the schedule hereto:
Schedule
Product:
Ervevax vaccine
Active Ingredient(s):
Rubella virus (Wistar RA27/3 strain) 1,000TCID50
Dosage Form:
Powder for injection
NZ Sponsor:
SmithKline Beecham (NZ) Limited
Manufacturer(s):
SmithKline Beecham Biologicals SA, Rixensart, Belgium
Product:
Priorix
Active Ingredient(s):
Rubella virus (Wistar RA27/3 strain) 1,000CCID50
Measles vaccine (Schwarz strain) 1,000CCID50
Mumps virus, live attenuated (RIT 4385) 5,012CCID50
Dosage Form:
Powder for injection
NZ Sponsor:
SmithKline Beecham (NZ) Limited
Manufacturer(s):**
Sachsisches Serumwerk Dresden, Branch of SKB Pharma GmbH, Dresden, Germany
SmithKline Beecham Biologicals SA, Rixensart, Belgium
SmithKline Beecham Biologicals SA, Genval, Belgium
Product:
Rimevax
Active Ingredient(s):
Measles vaccine (Schwarz strain) 1,000TCID50
Dosage Form:
Powder for injection
NZ Sponsor:
SmithKline Beecham (NZ) Limited
Manufacturer(s):**
SmithKline Beecham Biologicals SA, Rixensart, Belgium
Dated this 12th day of January 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go397
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the schedule hereto:
Schedule
Product:
Viracept
Active Ingredient(s):
Nelfinavir mesylate 58.5mg/g equivalent to 50mg/g nelfinavir free base
Dosage Form:
Powder for oral solution
NZ Sponsor:
Roche Products (New Zealand) Limited
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2000, No 4
Gazette.govt.nz —
NZ Gazette 2000, No 4
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare12 January 2000
Medicines Act, New medicine distribution, Asmanex Twisthaler, Mometasone furoate, Clomhexal, Clomiphene citrate, Zolaten, Aciclovir
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare12 January 2000
Medicines Act, Changed medicine distribution, Ervevax vaccine, Rubella virus, Priorix, Measles vaccine, Mumps virus, Rimevax
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Renewal of Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare12 January 2000
Medicines Act, Provisional consent renewal, Viracept, Nelfinavir mesylate
- G. R. Boyd, Chief Advisor, Safety and Regulation